Help Patients Give Metformin a Fair Chance

December 2015

Diabetes patients will need your help sticking with metformin...since about 1 in 3 patients will have GI problems with it.

We know metformin is our go-to med for type 2s due to well-established safety and efficacy...possible CV benefits...and low cost. Plus it seems safer than previously thought in stable kidney disease.

But GI side effects can lead to poor adherence...impacting glucose control AND Star Ratings.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote